Singapore markets close in 2 hours

hVIVO plc (CRO.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.2140+0.0020 (+0.94%)
As of 08:05AM CET. Market open.
Full screen
Previous close0.2120
Open0.2140
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.2140 - 0.2140
52-week range0.0950 - 0.2440
Volume10,000
Avg. volume0
Market cap156.785M
Beta (5Y monthly)0.99
PE ratio (TTM)
EPS (TTM)0.0000
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date04 May 2023
1y target estN/A
  • Reuters

    hVIVO raises 2023 revenue view on demand for respiratory therapy testings

    Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.